A comparison of long-term healthcare utilization and costs in patients with acute severe ulcerative colitis receiving infliximab <i>versus</i> early colectomy.

Ther Adv Chronic Dis · 2019 · PMC6354298 · PMID 30728932

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

Similarly, a higher proportion of patients who received infliximab first and who subsequently required colectomy received only a single dose of infliximab ( versus two or three doses) compared with those who never subsequently required a colectomy, though again this did not reach statistical significance (56% versus 37%, p = 0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.